Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Next-generation sequencing (NGS) of liquid biopsies offers a minimally invasive alternative to solid tissue biopsies and a more holistic profile of intra- and inter-tumoral heterogeneity for therapy
selection and disease monitoring. However, NGS analysis of circulating tumor DNA (ctDNA) is highly
centralized owing to cumbersome workflows, complex assays, and a lack of high-performance kitted
solutions. We present a sensitive, scalable, and efficient targeted amplicon sequencing workflow and

Sponsored by